Cowen And Company, LLC Esperion Therapeutics, Inc. Put Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$19.4 - $28.71 $436,499 - $645,975
-22,500 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$25.12 - $36.89 $565,200 - $830,025
22,500 New
22,500 $95,000
Q3 2020

Nov 03, 2020
SELL
$31.18 - $52.71 $779,500 - $1.32 Million
-25,000 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$30.04 - $51.31 $751,000 - $1.28 Million
25,000 New
25,000 $34,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $155M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email